期刊
TRENDS IN PARASITOLOGY
卷 34, 期 9, 页码 735-746出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.pt.2018.07.001
关键词
-
类别
资金
- MRC [MR/N00227X/1]
- Medicines for Malaria Venture
- MRC [MR/N00227X/1] Funding Source: UKRI
Malaria remains a major global health challenge. Appropriate use of current antimalarial tools has reduced the disease burden, but morbidity and mortality remain unacceptably high. It is widely accepted that, to achieve long-term control/eradication, it will be necessary to use interventions that inhibit the transmission of parasites to mosquitoes - these tools are termed transmission-blocking interventions (TBIs). This article aims to outline the rationale for the development of TBIs, with a focus on transmission-blocking drugs and (parasite-derived) transmission-blocking vaccines. We describe and summarise the current status of each of these intervention classes and attempt to identify future requirements in development, with a focus on the challenges of establishing each method within an integrated malarial control programme in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据